![]() |
市場調查報告書
商品編碼
1700082
2032 年螯合硒市場預測:按螯合劑、形態、等級、應用和地區分類的全球分析Chelated Selenium Market Forecasts to 2032 - Global Analysis By Chelating Agent (Glycine, Methionine and Other Chelating Agents), Form (Powder, Liquid and Granules), Grade, Application and By Geography |
根據 Stratistics MRC 的數據,全球螯合硒市場預計在 2025 年達到 8.6 億美元,到 2032 年將達到 14.1 億美元,預測期內的複合年成長率為 7.3%。
螯合硒是硒的一種形式,它與有機分子(如氨基酸或胜肽)結合,以增加生物有效性和吸收率。它廣泛用於農業、膳食補充劑和動物營養,以促進抗氧化活性、免疫系統功能和整體健康。與無機硒源相比,螯合物增加了硒的穩定性和可用性,使其更有效地被人體利用。
根據國際飼料工業聯合會(IFIF)的數據,全球每年生產超過10億噸複合飼料。
動物營養需求不斷成長
動物營養中對螯合硒的需求不斷增加,因為它在提高牲畜健康和生產力方面發揮著重要作用。硒是一種重要的微量營養素,可以改善牲畜的免疫功能、生育能力和生長率,這與人們對高品質肉類和乳製品的日益關注相吻合。此外,嚴格的法規要求在飼料中補充硒以防止缺乏,這進一步推動了硒的採用。集約化農業的興起和消費者對符合道德標準的畜產品的需求也促進了市場的成長。
嚴格遵守法規
FDA 和 EFSA 等機構強制限制硒的含量以防止過量攝取,製造商必須經過複雜的核准程序。遵守當地標準會增加生產成本並延遲產品發布,尤其是對於較小的營運商。此外,頻繁更新的安全指南需要不斷地進行再製造,這給業務帶來了挑戰。這些因素共同限制了市場可及性和增加了進入壁壘,從而抑制了市場成長。
人類營養補充品的擴展
硒具有公認的抗氧化作用,可以對抗氧化壓力並支持甲狀腺和免疫功能。慢性病的增加和人口老化正在推動對硒強化產品的需求。此外,個人化營養和潔淨標示補充劑的趨勢正在推動甲硫胺酸等配方的創新。向新興市場的擴張,加上健康意識的增強,使人類營養成為市場參與者的有利可圖的成長途徑。
潛在的毒性問題
儘管過量攝取會帶來毒性風險,包括硒中毒,這會損害器官和神經系統。這些擔憂導致監管審查加大,消費者懷疑情緒加劇,尤其是在不受監管的市場。過度添加牲畜或人類產品可能導致召回、法律責任和聲譽損害。此外,原物料採購品管不一致加劇了安全風險。這些因素威脅市場穩定,需要嚴格的品質保證和消費者教育來減輕負面影響。
新冠疫情擾亂了全球供應鏈,導致螯合硒市場原料短缺、生產延遲。停工減少了畜牧業的需求,經濟的不確定性減緩了研發投資。相反,健康意識的提高刺激了對增強免疫力的補充劑的需求,部分抵消了損失。農業和營養保健品的疫情後復甦,加上供應鏈的穩定,正在推動市場逐步復甦。
預計甘氨酸市場在預測期內將佔據最大佔有率
預計甘氨酸將在預測期內佔據最大的市場佔有率,因為其優異的生物利用度和穩定性使其成為動物飼料和藥品的理想選擇。它的成本效益和與各種配方的兼容性增強了其在畜牧業和水產養殖業的應用。此外,甘胺酸在降低植物氧化壓力方面的作用擴大了其在農業應用中的用途。由於其成熟的供應鏈和在預防硒缺乏方面已證實的有效性,該領域鞏固了其主導地位,特別是在集約農業地區。
預計在預測期內,液體部分將以最高的複合年成長率成長。
由於液體易於融入飼料混合物、肥料和營養補充劑中,預計預測期內液體部分將出現最高的成長率。液體螯合硒具有精確劑量和快速吸收的特點,對現代農業和精密農業具有吸引力。家禽和乳製品產業對液體補充劑的需求不斷增加,加上封裝技術的進步,將進一步推動成長。此外,水耕和葉面噴布在園藝中的廣泛應用將推動其應用,預計這一領域將出現強勁成長。
在預測期內,由於嚴格的動物營養法規、先進的農業實踐以及消費者對膳食補充劑的高度認知,預計北美將佔據最大的市場佔有率。該地區畜牧業發達,非常注重肉類質量,這導致對富硒飼料的需求增加。此外,強大的研發能力以及阿徹丹尼爾斯米德蘭和嘉吉等主要企業的存在增強了市場主導地位。政府推動食品和飼料微量營養素強化的措施進一步加強了北美的主導地位。
由於畜牧業產量擴大、肉類消費量增加以及健康意識增強,預計亞太地區在預測期內的複合年成長率最高。中國和印度等國家正在投資現代農業技術和營養補充劑來解決硒缺乏問題。政府支持農業生產力的政策和都市化對加工食品的需求進一步刺激了人們的採用。此外,低生產成本和新興經濟體尚未開發的潛力使該地區成為吸引全球對螯合硒應用投資的高成長市場。
According to Stratistics MRC, the Global Chelated Selenium Market is accounted for $0.86 billion in 2025 and is expected to reach $1.41 billion by 2032 growing at a CAGR of 7.3% during the forecast period. Chelated selenium is a form of selenium bound to organic molecules, such as amino acids or peptides, to enhance bioavailability and absorption. It is extensively utilized in agriculture, nutritional supplements, and animal nutrition to promote antioxidant activity, immune system function, and general health. Compared to inorganic selenium sources, chelation increases the stability and efficacy of selenium, allowing the body to use it more effectively.
According to the International Feed Industry Federation (IFIF), over 1 billion tons of compound animal feed are produced annually worldwide.
Rising demand in animal nutrition
The increasing demand for chelated selenium in animal nutrition is driven by its critical role in enhancing livestock health and productivity. As a vital micronutrient, selenium improves immune function, fertility, and growth rates in animals, aligning with the growing focus on high-quality meat and dairy products. Additionally, stringent regulations mandating selenium supplementation in animal feed to prevent deficiencies further propel adoption. The rise in intensive farming practices and consumer demand for ethically sourced animal products also contribute to market growth.
Stringent regulatory compliance
Agencies like the FDA and EFSA enforce limits on selenium concentrations to prevent overexposure, requiring manufacturers to navigate complex approval processes. Compliance with regional standards increases production costs and delays product launches, particularly for small-scale players. Moreover, frequent updates to safety guidelines necessitate continuous reformulation, creating operational challenges. These factors collectively restrain market growth by limiting accessibility and increasing barriers to entry.
Expansion in human nutritional supplements
Recognized for its antioxidant properties, selenium combats oxidative stress and supports thyroid and immune functions. Rising prevalence of chronic diseases and aging populations amplify demand for selenium-enriched products. Furthermore, the trend toward personalized nutrition and clean-label supplements drives innovation in formulations like selenomethionine. Expansion into emerging markets, coupled with increasing health awareness, positions human nutrition as a lucrative growth avenue for market players.
Potential toxicity issues
Despite its benefits, excessive selenium intake poses toxicity risks, including selenosis, which can damage organs and nervous systems. Such concerns heighten regulatory scrutiny and consumer skepticism, particularly in unregulated markets. Incidents of over-supplementation in livestock or human products could lead to recalls, legal liabilities, and reputational damage. Additionally, inconsistent quality control in raw material sourcing exacerbates safety risks. These factors threaten market stability, necessitating rigorous quality assurance and consumer education to mitigate adverse impacts.
The Covid-19 pandemic disrupted global supply chains causing raw material shortages and production delays in the chelated selenium market. Lockdowns reduced demand from the livestock sector due to operational halts, while economic uncertainties slowed R&D investments. Conversely, heightened health awareness boosted demand for immune-boosting supplements, partially offsetting losses. Post-pandemic recovery in agriculture and nutraceuticals, coupled with stabilized supply chains, has driven gradual market resurgence.
The glycine segment is expected to be the largest during the forecast period
The glycine segment is expected to account for the largest market share during the forecast period due to its superior bioavailability and stability, making it ideal for animal feed and pharmaceuticals. Its cost-effectiveness and compatibility with diverse formulations enhance adoption in livestock and aquaculture industries. Additionally, glycine's role in reducing oxidative stress in plants amplifies its use in agricultural applications. The segment's established supply chain and proven efficacy in preventing selenium deficiencies solidify its leading position, particularly in regions with intensive farming practices.
The liquid segment is expected to have the highest CAGR during the forecast period
Over the forecast period, the liquid segment is predicted to witness the highest growth rate attributed to its ease of integration in feed mixes, fertilizers, and nutraceuticals. Liquid chelated selenium offers precise dosing and faster absorption, appealing to modern farming and precision agriculture. Rising demand for liquid supplements in poultry and dairy industries, coupled with advancements in encapsulation technologies, further drives growth. Additionally, expanding applications in hydroponics and foliar sprays in horticulture bolster its adoption, positioning this segment for robust expansion.
During the forecast period, the North America region is expected to hold the largest market share due to stringent animal nutrition regulations, advanced agricultural practices, and high consumer awareness of dietary supplements. The region's well-established livestock industry and emphasis on meat quality drive demand for selenium-enriched feed. Moreover, strong R&D capabilities and the presence of key players like Archer Daniels Midland and Cargill enhance market dominance. Government initiatives promoting micronutrient fortification in food and feed further solidify North America's leading position.
Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR due to expanding livestock production, rising meat consumption, and increasing health consciousness. Countries like China and India are investing in modern farming techniques and nutritional supplements to address selenium deficiencies. Government policies supporting agricultural productivity and urbanization-driven demand for processed foods further accelerate adoption. Additionally, low production costs and untapped potential in emerging economies position the region as a high-growth market, attracting global investments in chelated selenium applications.
Key players in the market
Some of the key players in Chelated Selenium Market include BASF SE, DSM-Firmenich, Cargill, Incorporated, Archer Daniels Midland Company (ADM), Alltech, Zinpro Corporation, Novus International, Inc., Kemin Industries, Inc., Nutreco, Phibro Animal Health Corporation, Lallemand Animal Nutrition, DLG Group, Vitatrace Nutrition, Balchem Corporation, Orffa International B.V., Biochem (EW Group), Virbac SA and Mercer Milling Company.
In September 2024, HarvestPlus and Cargill are excited to announce the NutriHarvest project, a transformative 36-month initiative. This $3 million multi-year project, supported by Cargill and executed by HarvestPlus, is dedicated to increasing access to nutritious food while impacting more than 119,000 farmers across India, Kenya, Tanzania, and Guatemala, and delivering over 17 million nutritious meals.
In August 2024, Fonterra is set to expand its Studholme site in the South Island to create a hub for high value proteins. Fonterra's proteins have enhanced functionality and are designed to perform well in premium product applications such as medical and high-protein sports nutrition. Fonterra CEO Miles Hurrell says the investment of around $75 million is part of the Co-op's strategy to grow value through its world-leading Ingredients business by partnering with customers who value Fonterra's unique offering.
Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.